Quality-adjusted life year

health indicator combining quality and duration of life into a cumulative metric

Commentary Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
Sep 09 2015
Why I'm Not Worried About Drug Prices How I Stopped Worrying And Learned To Love The $100,000 Drug
By Yevgeniy Feyman Read time 6 mins Read More
Commentary Health, Health FDA Reform, Pharmaceuticals
Apr 13 2015
Is Pharmaceutical Productivity In Decline? Maybe Not
By Yevgeniy Feyman Read time 5 mins Read More
Commentary Economics, Health, Health Healthcare
Dec 12 2014
The Cost And Value Of Drugs Part Two: Benefits And Effectiveness
By Yevgeniy Feyman Read time 5 mins Read More
Commentary Health Pharmaceuticals
Nov 11 2014
Cancer Drug Prices: A Convenient Scapegoat for a Complex Problem
By Paul Howard Read time 5 mins Read More
Commentary Health, Health FDA Reform, Pharmaceuticals
Aug 18 2014
UK Says Sovaldi Is Worth It. We Should Listen
By Yevgeniy Feyman Read time 4 mins Read More
Commentary Health
Jun 20 2014
This Is What Health Insurance Should Look Like
By Yevgeniy Feyman Read time 6 mins Read More
Commentary Health, Health Healthcare
Jun 28 2011
Obamacare's 'One Size Fits All' Health Care Guidelines
By Paul Howard Read time 4 mins Read More
Report Health FDA Reform, Pharmaceuticals
Jun 28 2011
Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
By Eric Sun, Tomas J. Philipson Read time 6 mins Read More
Commentary Health, Health Healthcare
May 19 2010
A Regrettable Reform
By David Gratzer Read time 14 mins Read More
Commentary Health
Aug 17 2009
The Panel
By Andrew Klavan Read time 4 mins Read More